Juan Sanchez | Vice President of Corporate Communications and Investor Relations |
Sharon Mates | Founder, Chairman and Chief Executive Officer |
Mark Neumann | Executive Vice President, Chief Commercial Officer |
Larry Hineline | Senior Vice President of Finance and Chief Financial Officer |
Suresh Durgam | Executive Vice President, Chief Medical Officer |
Andrew Tsai | Jefferies |
Marc Goodman | SVB Leerink |
Charles Duncan | Cantor Fitzgerald |
Jason Gerberry | Bank of America |
Michael Riad | Morgan Stanley |
Sumant Kulkarni | Canaccord Genuity |
Corinne Jenkins | Goldman Sachs |
Ash Verma | UBS |
David Amsellem | Piper Sandler |
Umer Raffat | Evercore ISI |
Ami Fadia | Needham & Company, LLC |
Graig Suvannavejh | Mizuho Securities |
Good morning. And welcome to Intra-Cellular Therapies Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today’s conference call is being recorded.